Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Clinical trial NCT02471222 · COMPLETED
Trial details
- NCT number
- NCT02471222
- Sponsor
- Adamas Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2016-06-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.